Additional key phrases: free erythrocyte protoporphyrin; porphyrins; neonate Erythropoietic protoporphyria (EPP) is one of the more common forms of inherited porphyria. It is caused by a partial decrease in ferrochelatase activity and is inherited as an autosomal dominant trait with variable penetrance. Clinically, the disorder generally begins in childhood and is characterized by photosensitive skin lesions, especially of the face and hands. Liver disease (particularly gallstones) may be seen in some patients. Diagnosis is usually made by demonstrating increased free erythrocyte protoporphyrin and plasma total porphyrin concentration. There may also be accumulation of protoporphyrin in faeces. Assays which demonstrate normal urinary porphyrin excretion and reduced levelsof ferrochelatase in lymphocytes can also be used for confirmation, but are infrequently employed as they provide no additional overall information. We recently had the opportunity of analysing cord blood for porphyrins from a full-term baby fathered by a patient who had previously been diagnosed with EPP.
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Cord blood was collected into a heparinized container and an aliquot was centrifuged for assay of the plasma. Reference ranges were established from determinations made on 10full-term neonatal cord blood samples, similarly treated. Faeces were collected into a darkened faecal pot and specimens were stored at -WOC until analysis and protected from light at all times. Total porphyrins in plasma and faeces were quantified by the methods of Chisolm and Brown! and Lockwood et aU respectively. Erythrocyte free-and zinc-protoporphyrin! and faecal porphyrins" were measured by high-performance liquid chromatography with fluorescence detection. Plasma ferritin was measured by radioimmunoassay, and blood lead was determined using atomic absorption spectroscopy.
The infant had greatly increased free erythrocyte protoporphyrin and plasma total porphyrin when Correspondence: Dr N R Badcock. measured in cord blood compared with values from the normal controls (Table 1) . Similar results were obtained when the analyses were repeated at age 6 months. Erythrocyte zinc protoporphyrin, blood lead, plasma ferritin and faecal porphyrin excretion were normal, the latter result reflecting the absence of any hepatobiliary involvement at this stage. M Although cord blood has not previously been used to diagnose porphyria, several studies have investigated iron and lead status using cord blood and demonstrated marginally increased levels of free erythrocyte protoporphyrin.l-" Whilst this may reflect increased maternal blood levels, it is much more likely (in the absence of evidence of maternal EPP) to be related to diminished iron stores in the mother. Neither plasma ferritin nor blood lead levels, however, were different in our infant to values obtained in normal controls. The erythrocyte total porphyrin of 5· 8 /LmollL was several fold higher than values recorded in iron deficiency states 7 • 8 and, importantly, plasma total porphyrin (found in plasma of patients withEPP but not in iron deficiencyanaemia and lead intoxication) was grossly elevated (fable 1). We believe the cord blood results, in the context of the family history, were diagnostic of EPP in this infant.
At age 6 months, the infant remains free of cutaneous symptoms. It could be some time before photosensitivity occurs if at all: meanwhile, with the early diagnosis it may be possible that clinical expression can be avoided or reduced through the avoidance of sunlight exposure, the use of topical sunscreen creams and, when applicable, the prompt administration of {j-carotene to ameliorate symptoms.
